27:
1034:
269:
245:
217:
189:
162:
1048:
401:
as a strategic move to garner partnerships with other biotechnology companies. However, the company also had an office in
Denmark, in which it received a crucial part of its early investments from BankInvest, under managing director Florian Schönharting, Kommunernes Pensionsforsikring A/S and Dansk
402:
KapitalanlĂŠg
Aktieselskab as well as private investor Lars Christiansen. At the time, the company had fifty employees, fourteen of whom were in the Denmark office. The focus of the company in its early years was on genetic screens for receptors, aiming to accelerate early stage drug discovery.
421:
were collaborating on development of a treatment for glaucoma, and
Allergan would retain a 6.3% ownership stake in Acadia after the IPO. However, the company's IPO, which ultimately took place in May 2004, did not fare as well as expected and netted only
335:
Nuplazid, a drug developed by Acadia in the late 1990s, "was designed to stimulate a subset of the brainâs serotonin receptors, or the proteins that govern memory, cognition and learning." On April 29, 2016, the
426:. At the time, the company had five drugs in development and was running two in human trials. The company had a subsequent round of stock offering in May 2007 which raised
445:
at the time, Leonard R. Borrmann, left Acadia to lead Maret
Pharmaceuticals. He was succeeded by Uli Hacksell, who left Acadia to lead Cerecor at the beginning of 2016.
597:
1069:
1074:
1084:
640:"ACADIA Pharmaceuticals Initiates Phase II Trial of Pimavanserin for Adjunctive Treatment in Patients With Negative Symptoms of Schizophrenia"
1023:. Vol. 178, no. 357. Baltimore, Maryland: Tribune Publishing Company. December 23, 2015. p. 10 – via Newspapers.com.
586:. Vol. 115, no. 90. Hackensack, New Jersey: New Jersey Media Group. September 2, 2009. p. L-8 – via Newspapers.com.
1079:
547:. Vol. 115, no. 335. Hackensack, New Jersey: North Jersey Media Group. May 5, 2009. p. B-8 – via Newspapers.com.
502:
1094:
761:
1089:
639:
626:"ACADIA Pharmaceuticals Initiates Phase III Trial of Pimavanserin for Adjunctive Treatment in Patients with Schizophrenia"
625:
612:"ACADIA Pharmaceuticals Initiates Phase III Trial of Pimavanserin for Adjunctive Treatment in Patients with Schizophrenia"
611:
526:
944:. Vol. 134, no. 26 (Final ed.). Austin, Texas: Cox. Boston Globe. p. D2 – via Newspapers.com.
180:
962:. Vol. XXVI, no. 110. Minneapolis-St. Paul, Minnesota. July 23, 2007. p. D7 – via Newspapers.com.
355:
Acadia is running multiple Phase 2 and Phase 3 trials with pimavanserin in several central nervous system conditions:
728:
654:
490:. Vol. 36, no. 19 (Final ed.). West Palm Beach, Florida: Cox. p. 4A – via Newspapers.com.
973:
461:
1016:
937:
891:
998:
558:
433:
In
September 2020, Acadia Pharmaceuticals acquired clinical-stage biotechnology company CerSci Therapeutics.
348:, a selective serotonin inverse agonist preferentially targeting 5-HT2a receptors. Acadia had partnered with
483:
1005:. Vol. CXX, no. 86 (National ed.). February 27, 2001. p. C4 – via Newspapers.com.
863:
320:
955:
918:
360:
340:
approved Acadia's drug, Nuplazid, for the treatment of hallucinations and delusions associated with
442:
406:
138:
341:
124:
673:
925:. Vol. 266, no. 47. Boston, Massachusetts. p. C4 – via Newspapers.com.
166:
579:
540:
8:
352:
in the late-stage clinical testing of the drug, which showed trial failures as of 2009.
1039:
693:
394:
88:
66:
813:
739:
1053:
685:
565:. Ottawa, Ontario: Canwest. October 7, 2009. p. D3 – via Newspapers.com.
375:
260:
838:
16:
Pharmaceutical company, which developed
Nuplazid, based in San Diego, California.
409:(IPO) consisting of 31.6% of the company in 2001, with the intention of raising
397:. In 1997, the company relocated all operations and management from Vermont to
788:
418:
45:
26:
1063:
598:"Acadia Is Starting Phase 3 Trial of Nuplazid for Dementia-related Psychosis"
364:
53:
370:
As of 1997, Acadia was among several companies that licensed compounds from
697:
689:
345:
149:
71:
344:
psychosis. Nuplazid is the trade name for Acadia's proprietary molecule,
208:
93:
898:. Vol. CXX, no. 65. Bloomberg. February 6, 2001. p. C3
661:. Vol. 252, no. 172. p. C7 – via Newspapers.com.
398:
324:
385:
approved trofinetide (marketed as Daybue) for use in Rett syndrome.
674:"Trofinetide Receives FDA Approval as First Drug for Rett Syndrome"
356:
371:
349:
414:
62:
503:"Acadia Pharmaceuticals: This Is Not a Pharmaceutical Company"
974:"ACADIA Acquires CerSci Therapeutics to Boost Pain Portfolio"
236:
956:"Equity > Additional Equity > Piper Jaffrey & Co"
919:"As money-raisers, this year's biotech IPOs falling short"
393:
Acadia started in 1993 as
Receptor Technologies, based in
367:
inadequate response, and schizophrenia negative symptoms.
382:
337:
417:
exchange under the symbol ACAD. At the time, Acadia and
1017:"Cerecor's shares surge 25% after the CEO is replaced"
892:"Drug Developer Acadia Pharmaceuticals Files for IPO"
559:"Acadia, Biovail plan more study on Parkinson's drug"
1029:
297:
533:
1061:
319:is a biopharmaceutical company headquartered in
729:"Biotech with Danish ties settles on San Diego"
789:"Biotekpioneren fÄr milliarderne til at rulle"
1070:Pharmaceutical companies of the United States
864:""The initial plans you work with will fail""
839:"Biotekstjerne spottede de gode forretninger"
1075:Pharmaceutical companies established in 1993
958:. Quarterly Deal Report, 2nd Quarter, 2007.
462:"Acadia Pharmaceuticals Annual Report 2019"
786:
25:
1085:Health care companies based in California
655:"Bayer AG buys access to Genzyme library"
652:
762:"Acadia Pharmaceuticals SEC filing 2000"
735:. p. D1 – via Newspapers.com.
938:"A disappointing year for biotech IPOs"
935:
916:
836:
653:Rosenberg, Ronald (December 19, 1997).
507:The Foundation for Financial Journalism
436:
1062:
671:
481:
330:
886:
884:
756:
754:
752:
750:
748:
727:Fikes, Bradley J. (August 20, 1997).
726:
722:
720:
718:
716:
714:
999:"New Chief at Maret Pharmaceuticals"
936:Krasner, Jeffrey (August 23, 2004).
917:Krasner, Jeffrey (August 16, 2004).
574:
572:
500:
482:Singer, Stacey (November 26, 2005).
13:
881:
745:
742:", continuation of article, p. D2.
711:
484:"Jupiter's Abacoa site in the mix"
405:The company planned to conduct an
14:
1106:
1080:1993 establishments in California
787:VestergÄrd, Vibeke (2017-07-21).
569:
471:. ACADIA Pharmaceuticals for 10K.
1046:
1032:
268:
267:
244:
243:
216:
215:
188:
187:
161:
160:
1009:
991:
966:
948:
929:
910:
856:
830:
806:
780:
665:
646:
632:
618:
308:Footnotes / references
1095:Companies listed on the Nasdaq
604:
590:
551:
519:
494:
475:
454:
1:
837:Haaning, Karen (2018-10-20).
448:
1090:Companies based in San Diego
1001:. Orange County Newsmakers.
672:Harris, Emily (2023-03-22).
7:
906:– via Newspapers.com.
317:Acadia Pharmaceuticals Inc.
108:; 31 years ago
20:Acadia Pharmaceuticals Inc.
10:
1111:
501:Boyd, Roddy (2018-07-09).
388:
942:Austin American-Statesman
361:major depressive disorder
306:
292:
282:
258:
234:
206:
178:
155:
145:
131:
120:
102:
81:
51:
41:
33:
24:
443:chief executive officer
441:In 2001, the company's
407:Initial public offering
690:10.1001/jama.2023.4003
469:www.annualreports.com
399:San Diego, California
325:San Diego, California
125:San Diego, California
37:Receptor Technologies
437:Corporate governance
359:-related psychosis,
527:"FDA Press Release"
488:The Palm Beach Post
413:and listing on the
342:Parkinson's disease
331:Product development
288:570 (June 30, 2020)
284:Number of employees
21:
768:. 27 November 2020
733:North County Times
563:The Ottawa Citizen
374:'s small-molecule
273:US$ 699.14 million
249:US$ 783.18 million
137:Stephen R. Davis (
19:
1040:California portal
1021:The Baltimore Sun
1003:Los Angeles Times
896:Los Angeles Times
600:. 6 October 2017.
529:. April 29, 2016.
395:Winooski, Vermont
314:
313:
277:
253:
229:
201:
173:
89:Biopharmaceutical
1102:
1056:
1054:Companies portal
1051:
1050:
1049:
1042:
1037:
1036:
1035:
1025:
1024:
1013:
1007:
1006:
995:
989:
988:
986:
985:
980:. 26 August 2020
970:
964:
963:
952:
946:
945:
933:
927:
926:
923:The Boston Globe
914:
908:
907:
905:
903:
888:
879:
878:
876:
875:
860:
854:
853:
851:
850:
834:
828:
827:
826:
825:
810:
804:
803:
801:
800:
784:
778:
777:
775:
773:
758:
743:
736:
724:
709:
708:
706:
704:
669:
663:
662:
659:The Boston Globe
650:
644:
643:
636:
630:
629:
622:
616:
615:
608:
602:
601:
594:
588:
587:
576:
567:
566:
555:
549:
548:
537:
531:
530:
523:
517:
516:
514:
513:
498:
492:
491:
479:
473:
472:
466:
458:
429:
425:
412:
376:compound library
302:
299:
278:
275:
274:
271:
270:
263:
254:
251:
250:
247:
246:
239:
230:
227:
226:
224:
219:
218:
202:
199:
198:
196:
191:
190:
181:Operating income
174:
171:
170:
164:
163:
116:
114:
109:
29:
22:
18:
1110:
1109:
1105:
1104:
1103:
1101:
1100:
1099:
1060:
1059:
1052:
1047:
1045:
1038:
1033:
1031:
1028:
1015:
1014:
1010:
997:
996:
992:
983:
981:
972:
971:
967:
954:
953:
949:
934:
930:
915:
911:
901:
899:
890:
889:
882:
873:
871:
862:
861:
857:
848:
846:
835:
831:
823:
821:
812:
811:
807:
798:
796:
785:
781:
771:
769:
760:
759:
746:
737:
725:
712:
702:
700:
670:
666:
651:
647:
638:
637:
633:
624:
623:
619:
610:
609:
605:
596:
595:
591:
580:"Market Movers"
578:
577:
570:
557:
556:
552:
541:"Market Movers"
539:
538:
534:
525:
524:
520:
511:
509:
499:
495:
480:
476:
464:
460:
459:
455:
451:
439:
428:US$ 102 million
427:
423:
410:
391:
333:
321:Sorrento Valley
310:
296:
285:
272:
266:
259:
248:
242:
235:
222:
220:
214:
211:
194:
192:
186:
183:
165:
159:
134:
112:
110:
107:
98:
77:
56:
17:
12:
11:
5:
1108:
1098:
1097:
1092:
1087:
1082:
1077:
1072:
1058:
1057:
1043:
1027:
1026:
1008:
990:
978:news.yahoo.com
965:
947:
928:
909:
880:
855:
829:
805:
779:
744:
710:
664:
645:
631:
617:
603:
589:
568:
550:
532:
518:
493:
474:
452:
450:
447:
438:
435:
424:US$ 35 million
411:US$ 64 million
390:
387:
332:
329:
312:
311:
304:
303:
294:
290:
289:
286:
283:
280:
279:
264:
256:
255:
240:
232:
231:
212:
207:
204:
203:
184:
179:
176:
175:
169:339.08 million
157:
153:
152:
147:
143:
142:
135:
132:
129:
128:
122:
118:
117:
104:
100:
99:
97:
96:
91:
85:
83:
79:
78:
76:
75:
69:
59:
57:
52:
49:
48:
43:
39:
38:
35:
31:
30:
15:
9:
6:
4:
3:
2:
1107:
1096:
1093:
1091:
1088:
1086:
1083:
1081:
1078:
1076:
1073:
1071:
1068:
1067:
1065:
1055:
1044:
1041:
1030:
1022:
1018:
1012:
1004:
1000:
994:
979:
975:
969:
961:
957:
951:
943:
939:
932:
924:
920:
913:
897:
893:
887:
885:
869:
865:
859:
844:
843:Berlingske.dk
840:
833:
819:
815:
809:
794:
793:Berlingske.dk
790:
783:
767:
763:
757:
755:
753:
751:
749:
741:
734:
730:
723:
721:
719:
717:
715:
699:
695:
691:
687:
683:
679:
675:
668:
660:
656:
649:
641:
635:
627:
621:
613:
607:
599:
593:
585:
581:
575:
573:
564:
560:
554:
546:
542:
536:
528:
522:
508:
504:
497:
489:
485:
478:
470:
463:
457:
453:
446:
444:
434:
431:
420:
416:
408:
403:
400:
396:
386:
384:
381:In 2023, the
379:
377:
373:
368:
366:
365:schizophrenia
362:
358:
353:
351:
347:
343:
339:
328:
326:
322:
318:
309:
305:
301:
295:
291:
287:
281:
265:
262:
257:
241:
238:
233:
225: million
223:−235.26
213:
210:
205:
197: million
195:−246.55
185:
182:
177:
168:
158:
154:
151:
148:
144:
140:
136:
130:
126:
123:
119:
105:
101:
95:
92:
90:
87:
86:
84:
80:
73:
70:
68:
64:
61:
60:
58:
55:
50:
47:
44:
40:
36:
32:
28:
23:
1020:
1011:
1002:
993:
982:. Retrieved
977:
968:
960:Star Tribune
959:
950:
941:
931:
922:
912:
900:. Retrieved
895:
872:. Retrieved
870:. 2019-12-13
867:
858:
847:. Retrieved
842:
832:
822:, retrieved
820:, 2020-11-26
817:
808:
797:. Retrieved
792:
782:
770:. Retrieved
765:
732:
701:. Retrieved
684:(14): 1142.
681:
677:
667:
658:
648:
634:
620:
606:
592:
583:
562:
553:
544:
535:
521:
510:. Retrieved
506:
496:
487:
477:
468:
456:
440:
432:
404:
392:
380:
369:
354:
346:pimavanserin
334:
316:
315:
307:
261:Total equity
237:Total assets
150:Pimavanserin
121:Headquarters
72:Russell 2000
42:Company type
845:(in Danish)
795:(in Danish)
772:27 November
1064:Categories
984:2020-09-13
874:2020-11-27
868:investiere
849:2020-11-27
824:2020-11-27
799:2020-11-27
584:The Record
545:The Record
512:2020-06-29
449:References
209:Net income
133:Key people
94:Healthcare
818:Knowledge
74:component
54:Traded as
814:"Genmab"
698:36947078
419:Allergan
357:dementia
146:Products
82:Industry
34:Formerly
740:Biotech
703:12 July
389:History
372:Genzyme
350:Biovail
293:Website
156:Revenue
111: (
103:Founded
65::
696:
415:NASDAQ
298:acadia
276:(2019)
252:(2019)
228:(2019)
200:(2019)
172:(2019)
127:, U.S.
63:Nasdaq
46:Public
902:7 Dec
465:(PDF)
904:2019
774:2020
705:2023
694:PMID
678:JAMA
300:.com
221:US$
193:US$
167:US$
113:1993
106:1993
67:ACAD
766:SEC
686:doi
682:329
383:FDA
338:FDA
139:CEO
1066::
1019:.
976:.
940:.
921:.
894:.
883:^
866:.
841:.
816:,
791:.
764:.
747:^
731:.
713:^
692:.
680:.
676:.
657:.
582:.
571:^
561:.
543:.
505:.
486:.
467:.
430:.
378:.
363:,
327:.
323:,
987:.
877:.
852:.
802:.
776:.
738:"
707:.
688::
642:.
628:.
614:.
515:.
141:)
115:)
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
